Sun Pharmaceutical Industries Ltd.
ShareSUNPHARMA Competitor Analysis
| SUNPHARMA | DIVISLAB  | TORNTPHARM | CIPLA | DRREDDY | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 28 Jan, 2026, 03:59 PM | 1,610.60 0% | 6,188.00 0% | 3,958.70 0% | 1,328.40 0% | 1,222.50 0% |
| Market cap (₹ Cr) | 3,86,437 | 1,64,272 | 1,33,980 | 1,07,302 | 1,02,028 |
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -0.42% | -0.76% | -0.24% | -1.15% | -1.99% |
| 1W | -4.05% | -5.41% | -1.79% | -8.33% | 4.14% |
| 1M | -5.09% | -6.47% | 3.03% | -12.68% | -2.66% |
| 3M | -3.27% | -6.63% | 9.95% | -16.14% | -4.17% |
| 6M | -4.13% | -8.7% | 8.54% | -16.35% | -4.02% |
| 1Y | -4.32% | 11.11% | 18.63% | -7.43% | 4.6% |
| 5Y | 189.16% | 75.28% | 195.23% | 56.19% | 26.81% |
Income StatementAnnual data as on 03 Feb 2026. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 52,578 8.41% | 9,360 19.31% | 11,516 7.35% | 27,548 6.88% | 32,644 16.54% |
| OPM (%) | 28 7.2% | 30.56 13.44% | 32.25 3.3% | 25.09 5.78% | 25.33 -7.72% |
| PBT | 13,752 24.03% | 2,916 34.81% | 2,673 13.65% | 6,821 19.62% | 7,658 6.57% |
PAT | 10,980 13.81% | 2,191 36.94% | 1,911 15.4% | 5,291 27.34% | 5,704 2.53% |
| Net Profit Margin | 20.85 5.2% | 23.41 14.75% | 16.6 7.51% | 19.13 18.67% | 17.54 -11.9% |
| EPS | 45.55 14.13% | 82.53 36.93% | 56.47 15.39% | 65.28 27.87% | 67.81 -79.72% |
Balance Sheet & Cash FlowAnnual data as on 03 Feb 2026. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 72,218 13.43% | 14,969 10.3% | 7,591 10.72% | 31,193 16.8% | 33,550 18.74% |
| Total Assets | 92,101 7.77% | 16,932 9.45% | 14,990 -0.47% | 37,387 14.27% | 49,427 27.18% |
| Total Outside Liabilities | 19,883 -8.78% | 1,963 3.37% | 7,399 -9.81% | 6,194 3.04% | 15,877 49.66% |
| Cash from Operating Activity | 14,072 15.96% | 1,653 31.09% | 2,585 -20.85% | 5,005 21.07% | 4,643 2.2% |
| Cash from Investment Activity | -5,306 -668.76% | -804 -198.88% | -540.05 -221.65% | -3,691 -23.53% | -5,808 -44.19% |
| Cash from Financing Activity | -7,906 -17.82% | -799 0% | -2,298 17.34% | -1,293 -7.75% | 1,891 602.52% |
| Net Cash Flow | 983.12 -78.91% | 50 -74.09% | -261.66 -180.11% | 30.31 161.87% | 748.6 463.7% |
RatiosAnnual data as on 03 Feb 2026. | |||||
| PB | 5.77 | 10.22 | 14.42 | 3.73 | 2.84 |
| PE | 35.36 | 74.98 | 70.10 | 20.35 | 18.04 |
| ROE (%) | 16.16 | 15.35 | 26.46 | 18.28 | 18.46 |
| Dividend Yield (%) | 0.99 | 0.48 | 0.81 | 1.20 | 0.65 |
| ROCE (%) | 20.86 | 20.45 | 27.55 | 23.64 | 23.48 |
